Clayface (2026) Review: Gross Fun, Safe Horror — James Watkins' Body-Horror Villain Movie Has the Stomach for Gore but Not for Risk

DC's horror-tinted detour into Matt Hagen's transformation delivers the body horror it promises in trailers, but most critics agree it pulls back exactly when the premise gets interesting.

Clayface, directed by James Watkins (Speak No Evil, The Woman in Black), opened in US theaters October 23, 2026, after its review embargo lifted October 21. It's DC Studios' lowest-budget theatrical swing yet at a reported $44 million, built around a villain most moviegoers have never heard of: Matt Hagen, a Gotham actor whose rise to Hollywood leading man is cut short when a crime boss leaves him disfigured, and who turns to an experimental treatment that restores his face but unravels his grip on reality. Tom Rhys Harries plays Hagen; Naomi Ackie, Eddie Marsan, David Dencik and Max Minghella round out the cast.

▶

Clayface details →YouTube ↗

What the reviews actually say

The Tomatometer sits at 77% from 96 counted reviews, with Metacritic's more conservative critic average landing at 59 — "mixed or average." That gap is itself the story: a majority of critics are willing to call Clayface a decent time, but few are calling it good without a qualifier attached. Variety's review leans into the positive side, calling it "good, gross fun" for embracing a body-horror register DC has mostly avoided on screen. Other outlets are less convinced the embrace goes far enough — a comparison piece noted the film's horror beats remain comparatively restrained for the genre, and at least one reviewer scored it as low as 2 out of 5, calling the lead performance dull and the film's late-film twist unearned after a slow middle stretch.

The actual disagreement: ambition versus execution

Strip away the star ratings and the critical split is consistent across both the positive and negative reviews: nearly everyone agrees Clayface is reaching for something DC hasn't tried before — a body-horror character study instead of another save-the-city tentpole — and nearly everyone agrees it doesn't fully commit to that reach. The most frequently repeated specific complaint is structural: the film sets up a genuinely strange premise (an actor's identity crisis literalized as shapeshifting flesh) and then resolves it through a conventional revenge-origin arc that several critics compared, unfavorably, to the creative swagger of Sam Raimi's Darkman or Alex Proyas' The Crow — films Clayface invites the comparison to and doesn't quite earn. One review went further, flagging that the inciting incident leans on a plot device (a false accusation against the male lead) that read as a tone-deaf choice to stage in 2026, regardless of how the rest of the film plays.

The one performance critics agree on

Across the range of scores, Naomi Ackie is the consistent bright spot. Even reviews otherwise unimpressed single her out as the film's most genuinely felt performance — one calling her "the only one expressing remotely compelling inner and ethical conflict" in a cast otherwise playing types. That's a notable split from Tom Rhys Harries' lead performance, which drew more mixed notice; some reviews credit him for physically committing to Hagen's transformation, while others found the performance flat during the film's quieter, non-transformed stretches — exactly the scenes meant to sell the tragedy underneath the gore.

Why DC Studios is making this bet at all

Clayface is also the first real stress test of James Gunn's stated plan for the rebooted DC Universe: that it can house wildly different tones and filmmakers under one banner instead of forcing every release through the same house style. It's an R-rated, horror-coded villain character study slotted between Superman and Supergirl on the release calendar, and reviewers have read it largely through that lens. The San Francisco Chronicle credited it with "largely" proving the point — that a DCU entry can go somewhere stranger than typical superhero spectacle and still work. The Independent singled out Tom Rhys Harries for projecting "wounded intensity" even under heavy prosthetic work, and The Daily Telegraph praised the film's willingness to follow its own instincts rather than soften them for a four-quadrant audience. The pushback is just as specific: USA Today flagged "a severe lack of character development" beneath the makeup, and Rolling Stone's pan compared the experience to "eating a handful of Play-Doh" — visually striking, but flavorless by the time the credits roll.

Should you see it

If you're going in for body horror specifically, temper expectations: multiple reviews note the film holds back from its grossest ideas rather than leaning all the way in, which may disappoint anyone drawn in by the trailers' more extreme imagery. If you're going in for a DC movie that doesn't look or feel like the rest of the DC Universe slate, that part of the pitch holds up — critics agree this doesn't look like a Superman or Supergirl movie, even when they disagree on whether the story underneath earns the different coat of paint. At a modest $44 million budget and a soft opening-weekend tracking of roughly $18-20 million, Clayface doesn't need blockbuster numbers to be considered a reasonable bet by DC Studios — which makes it a lower-risk watch for curious genre fans than its box-office ceiling might suggest.